scPharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Scpharmaceuticals

10/08/2023 22:02

* scPharmaceuticals Inc  SCPH.OQ  reported a quarterly
adjusted
loss of 36 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 37 cents per share.
    * Revenue was $1.64 million​; analysts expected $1.62
million. 
    * scPharmaceuticals Inc's reported EPS for the quarter was a
loss
of 36 cents​.
    * The mean earnings estimate of analysts had fallen by
about 8.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * scPharmaceuticals Inc shares had fallen by 23.0% this
quarter and gained 9.5% so far this year.
    * The company reported a quarterly loss of $14.15 million.
    * Wall Street's median 12-month price target for
scPharmaceuticals
Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.37          -0.36          Beat
 Mar. 31 2023      -0.36          -0.30          Beat
 Dec. 31 2022      -0.39          -0.30          Beat
 Sep. 30 2022      -0.38          -0.37          Beat